|
Topiramate
|
Topamax
|
4.4. Special warnings and precautions for use
|
Oct,2022
|
|
Canagliflozin
|
Invokana
|
4.5. Interactions with other medicinal products
|
Oct,2022
|
|
Ertugliflozin
|
Steglatro
|
4.5. Interactions with other medicinal products
|
Oct,2022
|
|
Ertugliflozin, Metformin Hydrochloride
|
Segluromet
|
4.5. Interactions with other medicinal products
|
Oct,2022
|
|
Ertugliflozin, Sitagliptin
|
Steglujan
|
4.5. Interactions with other medicinal products
|
Oct,2022
|
|
Dorzolamide
|
Trusopt
|
4.8 Undesirable effects
|
Nov,2022
|
|
Tozinameran (COVID-19 mRNA vaccine )
|
Comirnaty
|
4.8. Undesirable effects
|
Nov,2022
|
|
Elasomeran (COVID-19 mRNA vaccine )
|
Spikevax
|
4.8. Undesirable effects
|
Nov,2022
|
|
Durvalumab
|
Imfinzi
|
4.8. Undesirable effects
|
Nov,2022
|
|
Gabapentin
|
Neurontin
|
4.6 Fertility, pregnancy and lactation
|
Nov,2022
|
